Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial
JAMA 2020 Nov 12;[EPub Ahead of Print], EJ Lenze, C Mattar, CF Zorumski, A Stevens, J Schweiger, GE Nicol, JP Miller, L Yang, M Yingling, MS Avidan, AM ReiersenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.